Search

Your search keyword '"Rizig, Mie"' showing total 158 results

Search Constraints

Start Over You searched for: Author "Rizig, Mie" Remove constraint Author: "Rizig, Mie"
158 results on '"Rizig, Mie"'

Search Results

1. The 2022 symposium on dementia and brain aging in low‐ and middle‐income countries: Highlights on research, diagnosis, care, and impact

2. The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson’s disease

3. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study

4. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease

5. APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s disease

6. WARS2 mutations cause dopa-responsive early-onset parkinsonism and progressive myoclonus ataxia

7. p.L1795F LRRK2 variant is a common cause of Parkinson’s disease in Central Europe

9. An exploration of the genetics of the mutant Huntingtin (mHtt) gene in a cohort of patients with chorea from different ethnic groups in sub‐Saharan Africa

11. Metabolomic profiling reveals altered phenylalanine metabolism in Parkinson’s disease in an Egyptian cohort

14. Central European Group on Genetics of Movement Disorders

15. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

16. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study

17. GBA1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson’s Disease in Nigerians.

18. The non-codingGBA1rs3115534 variant is associated with REM sleep behavior disorder in Nigerians

20. Detection of prodromal Parkinson's disease using targeted urine proteomics and machine learning

21. MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset

22. The State of Play of Parkinson’s Disease in Africa: A Systematic Review and Point of View

23. Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome

26. Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease

27. Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson’s Disease in African and African Admixed Populations

28. The Nairobi Declaration—Reducing the burden of dementia in low‐ and middle‐income countries (LMICs): Declaration of the 2022 Symposium on Dementia and Brain Aging in LMICs

31. An exploration of the genetics of the mutant Huntingtin (mHtt) gene in a cohort of patients with chorea from different tribes in 6 sub-Saharan African countries

32. APOE E4 is associated with cognitive decline but not with disease risk or age of onset in Nigerians with Parkinson’s disease

33. Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions

35. Prevalence of Fabry Disease among Patients with Parkinson’s Disease

36. A Cross‐Sectional Comprehensive Assessment of the Profile and Burden of Non‐motor Symptoms in Relation to Motor Phenotype in the Nigeria Parkinson Disease Registry Cohort

37. LRRK2 mutations in Parkinson's disease patients from Central Europe: A case control study

38. Identification of candidate parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets

39. Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease

40. Identification of sixteen novel candidate genes for late onset Parkinson's disease

42. Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions.

43. LRRK2 mutations in Parkinson's disease patients from Central Europe: A case control study

44. A homozygous MED11 C-terminal variant causes a lethal neurodegenerative disease

47. The Nigeria Parkinson Disease Registry: Process, Profile, and Prospects of a Collaborative Project

48. Parkinson’s Disease in Kazakhstan: Clinico-Demographic Description of a Large Cohort

49. LRRK2 Mutations and Asian Disease-Associated Variants in the First Parkinson’s Disease Cohort from Kazakhstan

50. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

Catalog

Books, media, physical & digital resources